| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.12 mm | 2.12 mm | 2.12 mm | 2.12 mm | 2.12 mm | 2.12 mm |
| Cash burn (monthly) | 3.31 mm | 2.16 mm | 7.38 mm | 3.99 mm | 3.28 mm | 2.48 mm |
| Cash used (since last report) | 76.31 mm | 49.73 mm | 170.20 mm | 92.03 mm | 75.74 mm | 57.23 mm |
| Cash remaining | -74.19 mm | -47.61 mm | -168.08 mm | -89.92 mm | -73.62 mm | -55.11 mm |
| Runway (months of cash) | -22.4 | -22.1 | -22.8 | -22.5 | -22.4 | -22.2 |
| 13F holders | Current |
|---|---|
| Total holders | 3 |
| Opened positions | 0 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 79.00 k |
| Total shares | 358.09 k |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Castellina Ventures | 277.00 k | $0.00 |
| Pillar Pharmaceuticals 6 | 80.80 k | $79.00 k |
| Caldwell Sutter Capital | 294.00 | $0.00 |
